791 related articles for article (PubMed ID: 21430780)
1. DHODH modulates transcriptional elongation in the neural crest and melanoma.
White RM; Cech J; Ratanasirintrawoot S; Lin CY; Rahl PB; Burke CJ; Langdon E; Tomlinson ML; Mosher J; Kaufman C; Chen F; Long HK; Kramer M; Datta S; Neuberg D; Granter S; Young RA; Morrison S; Wheeler GN; Zon LI
Nature; 2011 Mar; 471(7339):518-22. PubMed ID: 21430780
[TBL] [Abstract][Full Text] [Related]
2. RNA helicase DDX21 mediates nucleotide stress responses in neural crest and melanoma cells.
Santoriello C; Sporrij A; Yang S; Flynn RA; Henriques T; Dorjsuren B; Custo Greig E; McCall W; Stanhope ME; Fazio M; Superdock M; Lichtig A; Adatto I; Abraham BJ; Kalocsay M; Jurynec M; Zhou Y; Adelman K; Calo E; Zon LI
Nat Cell Biol; 2020 Apr; 22(4):372-379. PubMed ID: 32231306
[TBL] [Abstract][Full Text] [Related]
3. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
[TBL] [Abstract][Full Text] [Related]
4. Developmental chromatin programs determine oncogenic competence in melanoma.
Baggiolini A; Callahan SJ; Montal E; Weiss JM; Trieu T; Tagore MM; Tischfield SE; Walsh RM; Suresh S; Fan Y; Campbell NR; Perlee SC; Saurat N; Hunter MV; Simon-Vermot T; Huang TH; Ma Y; Hollmann T; Tickoo SK; Taylor BS; Khurana E; Koche RP; Studer L; White RM
Science; 2021 Sep; 373(6559):eabc1048. PubMed ID: 34516843
[TBL] [Abstract][Full Text] [Related]
5. A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation.
Kaufman CK; Mosimann C; Fan ZP; Yang S; Thomas AJ; Ablain J; Tan JL; Fogley RD; van Rooijen E; Hagedorn EJ; Ciarlo C; White RM; Matos DA; Puller AC; Santoriello C; Liao EC; Young RA; Zon LI
Science; 2016 Jan; 351(6272):aad2197. PubMed ID: 26823433
[TBL] [Abstract][Full Text] [Related]
6. Nucleotide stress responses in neural crest cell fate and melanoma.
Sporrij A; Zon LI
Cell Cycle; 2021 Aug; 20(15):1455-1467. PubMed ID: 34281491
[TBL] [Abstract][Full Text] [Related]
7. KIT Suppresses BRAF
Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ
Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418
[TBL] [Abstract][Full Text] [Related]
8. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.
Ramgolam K; Lauriol J; Lalou C; Lauden L; Michel L; de la Grange P; Khatib AM; Aoudjit F; Charron D; Alcaide-Loridan C; Al-Daccak R
PLoS One; 2011 Apr; 6(4):e18784. PubMed ID: 21526207
[TBL] [Abstract][Full Text] [Related]
9. Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation.
Kumar SM; Dai J; Li S; Yang R; Yu H; Nathanson KL; Liu S; Zhou H; Guo J; Xu X
Oncogene; 2014 Feb; 33(7):832-41. PubMed ID: 23334329
[TBL] [Abstract][Full Text] [Related]
10. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C
Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656
[TBL] [Abstract][Full Text] [Related]
11. Neural crest state activation in NRAS driven melanoma, but not in NRAS-driven melanocyte expansion.
McConnell AM; Mito JK; Ablain J; Dang M; Formichella L; Fisher DE; Zon LI
Dev Biol; 2019 May; 449(2):107-114. PubMed ID: 29883661
[TBL] [Abstract][Full Text] [Related]
12. Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma.
Jalili A; Wagner C; Pashenkov M; Pathria G; Mertz KD; Widlund HR; Lupien M; Brunet JP; Golub TR; Stingl G; Fisher DE; Ramaswamy S; Wagner SN
J Natl Cancer Inst; 2012 Nov; 104(21):1673-9. PubMed ID: 22997239
[TBL] [Abstract][Full Text] [Related]
13. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset.
Ceol CJ; Houvras Y; Jane-Valbuena J; Bilodeau S; Orlando DA; Battisti V; Fritsch L; Lin WM; Hollmann TJ; Ferré F; Bourque C; Burke CJ; Turner L; Uong A; Johnson LA; Beroukhim R; Mermel CH; Loda M; Ait-Si-Ali S; Garraway LA; Young RA; Zon LI
Nature; 2011 Mar; 471(7339):513-7. PubMed ID: 21430779
[TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells.
O'Donnell EF; Kopparapu PR; Koch DC; Jang HS; Phillips JL; Tanguay RL; Kerkvliet NI; Kolluri SK
PLoS One; 2012; 7(7):e40926. PubMed ID: 22815870
[TBL] [Abstract][Full Text] [Related]
15. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
[TBL] [Abstract][Full Text] [Related]
16. Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.
Liu J; Rebecca VW; Kossenkov AV; Connelly T; Liu Q; Gutierrez A; Xiao M; Li L; Zhang G; Samarkina A; Zayasbazan D; Zhang J; Cheng C; Wei Z; Alicea GM; Fukunaga-Kalabis M; Krepler C; Aza-Blanc P; Yang CC; Delvadia B; Tong C; Huang Y; Delvadia M; Morias AS; Sproesser K; Brafford P; Wang JX; Beqiri M; Somasundaram R; Vultur A; Hristova DM; Wu LW; Lu Y; Mills GB; Xu W; Karakousis GC; Xu X; Schuchter LM; Mitchell TC; Amaravadi RK; Kwong LN; Frederick DT; Boland GM; Salvino JM; Speicher DW; Flaherty KT; Ronai ZA; Herlyn M
Cancer Res; 2021 Oct; 81(20):5230-5241. PubMed ID: 34462276
[TBL] [Abstract][Full Text] [Related]
17. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
Nazarian R; Shi H; Wang Q; Kong X; Koya RC; Lee H; Chen Z; Lee MK; Attar N; Sazegar H; Chodon T; Nelson SF; McArthur G; Sosman JA; Ribas A; Lo RS
Nature; 2010 Dec; 468(7326):973-7. PubMed ID: 21107323
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.
Patton EE; Widlund HR; Kutok JL; Kopani KR; Amatruda JF; Murphey RD; Berghmans S; Mayhall EA; Traver D; Fletcher CD; Aster JC; Granter SR; Look AT; Lee C; Fisher DE; Zon LI
Curr Biol; 2005 Feb; 15(3):249-54. PubMed ID: 15694309
[TBL] [Abstract][Full Text] [Related]
19. The Paf1 complex and P-TEFb have reciprocal and antagonist roles in maintaining multipotent neural crest progenitors.
Jurynec MJ; Bai X; Bisgrove BW; Jackson H; Nechiporuk A; Palu RAS; Grunwald HA; Su YC; Hoshijima K; Yost HJ; Zon LI; Grunwald DJ
Development; 2019 Dec; 146(24):. PubMed ID: 31784460
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide reduces proliferation and induces apoptosis in neuroblastoma cells in vitro and in vivo.
Zhu S; Yan X; Xiang Z; Ding HF; Cui H
PLoS One; 2013; 8(8):e71555. PubMed ID: 23977077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
